Chiropractic Offers Long Term Benefits for Fibromyalgia Sufferers

If you suffer with fibromyalgia, you are not alone, as Dr. Alpert sees many people with this particular syndrome in our Jonesboro chiropractic office. As a matter of fact, the Centers for Disease Control and Prevention (CDC) estimates that roughly two percent of all adults in the United States have fibromyalgia problems. Fortunately, chiropractic care is one treatment option that can provide positive results.

Research Shows Chiropractic Therapy Lessens Fibromyalgia Discomfort

In a paper released in mid-2015, 215 people with fibromyalgia were assessed based on factors ranging from pain to quality of sleep to the levels of depression and anxiety they felt. Then they were divided into two groups with one group receiving a multi-modal therapy program for three months and the second group receiving the same approach with the addition of chiropractic adjustments (specifically, to the upper neck area) for the same length of time.

The subjects who received chiropractic adjustments combined with the multi-modal treatment program reported greater results in all areas (pain, sleep, depression, and anxiety) at 12 weeks post-treatment when compared to the study participants who received multi-modal treatment without chiropractic therapy. Furthermore, those positive benefits were lasting as the patients reported continued improvement one full year later.

Fibromyalgia problems can significantly diminish your quality of life, both psychologically and physically. If you're suffering from fibromyalgia, we might be able to help.

You don't have to suffer! To see what Dr. Alpert can do for your fibromyalgia problems, call our Jonesboro chiropractic office today.

References

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.